AllianceBernstein
DICE

AllianceBernstein’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

AllianceBernstein’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-551,647
Closed -$25.6M – 3226
2023
Q2 		$25.6M Buy
551,647
+519,547
+1,619% +$18M 0.01% 773
2023
Q1 		$920K Buy
32,100
+5,200
+19% +$154K ﹤0.01% 2273
2022
Q4 		$839K Buy
26,900
+800
+3% +$26.1K ﹤0.01% 2371
2022
Q3 		$529K Buy
26,100
+3,500
+15% +$63.8K ﹤0.01% 2622
2022
Q2 		$351K Buy
+22,600
New +$389K ﹤0.01% 2828

AllianceBernstein's DICE Position: Q3 2023 in Review

AllianceBernstein sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 551,647 shares — an estimated $25.6M sold.

AllianceBernstein first reported a position in DICE in Q2 2022 and held it in 5 quarters. The position peaked at $25.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • AllianceBernstein reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • AllianceBernstein sold 551,647 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $25.6M.
  • AllianceBernstein first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • AllianceBernstein's DICE Therapeutics, Inc. Common Stock position peaked at $25.6M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on AllianceBernstein's 13F filing for Q3 2023, filed 14 Nov 2023.